Skip to main content
. 1999 Jun;37(6):1764–1770. doi: 10.1128/jcm.37.6.1764-1770.1999

TABLE 4.

Comparison of patient characteristics according to the outcome measures low and high infectivities and low and high pathogenicities

Characteristic Infectivity
Pathogenicity
Low (n = 224) High (n = 153) P value Low (n = 341) High (n = 45) P value
Mean (SD) age (yr) 45.0 (16.8) 42.7 (15.7) 0.18 44.6 (16.5) 39.7 (15.6) 0.06
No. (%) of subjects
 Group 1 34 (15.2) 20 (13.1) 0.57 50 (14.7) 6 (13.3) 0.81
 Group 2 148 (66.1) 99 (64.7) 0.78 223 (65.4) 29 (64.4) 0.90
 Group 3 42 (18.8) 34 (22.2) 0.41 68 (19.9) 10 (22.2) 0.72
 Female 46 (20.5) 34 (22.2) 0.70 71 (20.8) 10 (22.2) 0.83
 Male 178 (79.5) 119 (77.8) 270 (79.2) 35 (77.8)
 Asian 12 (5.4) 9 (5.9) 0.83 19 (5.6) 2 (4.4) 0.97
 Black 79 (35.3) 68 (44.4) 0.07 126 (37.0) 23 (51.1) 0.07
 Hispanic 16 (7.1) 14 (9.2) 0.48 28 (8.2) 3 (6.7) 0.95
 White 114 (50.9) 62 (40.5) 0.05 165 (48.4) 17 (37.8) 0.18
 Other 3 (1.3) 3 (0.9)
 HIV positive 107 (47.8) 62 (40.5) 0.16 161 (47.2) 15 (33.3) 0.08
 HIV negativea 117 (52.2) 91 (59.5) 180 (52.8) 30 (66.7)
 Ever smear positive 120 (53.6) 93 (60.8) 0.17 192 (56.3) 25 (55.6) 0.92
 Always smear negative 40 (17.9) 19 (12.4) 0.15 50 (14.7) 10 (22.2) 0.19
 More than three sputum smears 64 (28.6) 41 (26.8) 0.71 99 (29.0) 10 (22.2) 0.34
Mean no. of contacts (SD)
 Named 11.5 (29.6) 9.4 (20.5) 0.45 10.9 (27.3) 6.9 (11.8) 0.33
 Screened 10.9 (29.5) 8.6 (20.1) 0.40 10.2 (27.1) 6.4 (10.8) 0.35
 Followed up 10.5 (29.0) 8.2 (18.0) 0.38 9.7 (26.2) 6.4 (10.9) 0.40
a

Includes subjects whose HIV status is unknown.